Olaparib phase III SOLO-2 trial demonstrates significant PFS benefit in BRCA-mutated disease March 30, 2017Vol.40 No.03
Carfilzomib produces OS benefit vs. bortezomib in relapsed, refractory disease March 30, 2017Vol.40 No.03
Health Disparities Study: Minority Women Receive Poorer Care for Cervical Cancer February 28, 2017Vol.40 No.02
Pitt Study Finds Potential Marker of Drug Response in Many Cancer Types February 28, 2017Vol.40 No.02
